Partnering
At Zentiva, we partner with organisations that share our commitment to expanding access to high-quality, affordable healthcare. Together, we create meaningful impact across Europe and beyond.
Over 100 million people already rely on Zentiva’s products and services. By 2028, we aim to reach 1 in 5 people across Europe, working closely with organisations that share our values and sense of responsibility. Our partnerships help ensure a consistent supply of affordable medicines for those who need them most.
UK Partnering Opportunities
At Zentiva UK, we are always open to new partnerships that help expand access to high-quality, affordable medicines across the NHS and the wider UK healthcare sector. If you are interested in exploring UK-specific partnering deals, whether for distribution, co-marketing or licensing - our Business Development team are flexible and would love to hear from you.
We have capabilities in retail, hospital and branded generics, biosimilars, OTC products and value-added medicines. To review our existing portfolio, please view our product portfolio.
Our dedicated B2B platform offers a comprehensive range of services, including active pharmaceutical ingredients (APIs), contract manufacturing, and licensing of proprietary know-how. We bring deep expertise in key therapeutic areas such as cardiology, urology, oncology, neurology, and hormone-related treatments.
Prague Scientific delivers end-to-end development and scientific services, supporting every stage of the pharmaceutical lifecycle—from concept to compliant product maintenance. This includes API and formulation R&D, sustainable manufacturing, and scientific affairs such as regulatory and pharmacovigilance. Prague Scientific also fosters innovation through academic partnerships like The Pharmaceutical Applied Research Centre (PARC).
Open Innovation
We welcome new ideas and collaborations to improve medicines, simplify administration, and increase patient compliance.
Date of Preparation: March 2026 | Reference: 000820195